Enteral Feeding Devices Market to Reach USD 4.93 Billion by 2031 Amid Rising Chronic Disease Burden

Nutritional support has become an increasingly central component of modern patient care, particularly as populations age and chronic disease prevalence climbs globally. A detailed enteral feeding devices market report values the global industry at USD 2.85 billion in 2023, with growth expected to push the market to USD 4.93 billion by 2031 at a CAGR of 7.13%. This trajectory reflects the growing role these devices play in delivering essential nutrition to patients who are unable to consume food orally, whether due to illness, surgery, or developmental complications.

Pandemic Legacy Continues to Shape Demand

The lingering effects of the COVID-19 pandemic remain an underappreciated driver of enteral feeding devices demand. Severely ill patients, particularly those treated in intensive care units, frequently experienced compromised intestinal function, inflammation, and increased catabolic stress, all of which heightened the need for immediate and reliable nutrient delivery. Clinical guidelines issued by major nutrition-focused medical bodies recommended gastric enteral nutrition using devices equipped with flow regulators for severe cases, a recommendation that has left a durable imprint on hospital procurement practices even as acute pandemic pressures have eased.

Preterm Births and Neonatal Care Fuel Long-Term Growth

Beyond pandemic-related demand, rising rates of premature birth represent a structural growth driver for the market. Preterm infants, born before 37 weeks of gestation, face significant physiological challenges due to underdeveloped organ systems, making them particularly vulnerable to malnutrition and related complications. Enteral feeding plays a critical role in neonatal care by enabling precise control over nutrient intake, supporting gastrointestinal maturation, and fostering healthy immune function and growth. As global health organizations continue to track rising premature birth rates, ongoing innovation in neonatal-specific feeding devices is expected to remain a priority for manufacturers and healthcare providers alike.

Chronic Disease and the Aging Population

The broader demand backdrop is shaped by the rising global prevalence of chronic conditions such as cancer, diabetes, and neurological disorders, combined with a growing geriatric population that increasingly requires reliable nutritional support. As healthcare systems place greater emphasis on patient nutrition as a determinant of recovery and overall well-being, enteral feeding devices are becoming an increasingly standard component of care pathways across hospital and home settings alike.

The Shift Toward Home-Based Care

One of the most consequential trends reshaping the market is the accelerating shift toward home-based healthcare delivery. Patients increasingly prefer the convenience and independence of receiving nutritional support outside a clinical setting, prompting manufacturers to redesign devices with an emphasis on intuitive operation, portability, and rigorous safety standards suitable for non-clinical use. This shift is not simply a matter of patient preference; it also reflects broader healthcare system priorities around reducing hospital length of stay and associated costs, making home-compatible enteral feeding technology an area of sustained manufacturer investment.

Closed Systems Improve Safety and Versatility

Closed system technology has emerged as one of the most significant innovations in enteral nutrition delivery. By providing a sealed pathway for nutrient administration, closed systems significantly reduce the risk of contamination and infection compared to traditional open systems, shielding both the feeding tube and the patient from external contaminants. These systems also offer versatility, supporting the administration of nutrition, medications, and other treatments through a single feeding tube — a capability that enhances both clinical efficiency and patient safety, and one that businesses are increasingly leveraging to differentiate their product portfolios.

Segment Analysis: Feeding Tubes and the Adult Population Lead

By product type, enteral feeding tubes led the market in 2023 with a valuation of USD 1.04 billion. Ranging from nasogastric tubes to specialized configurations, these devices remain essential for delivering nutrients directly into the gastrointestinal tract, with compatibility across modern closed systems and device connectors further enhancing their clinical utility and safety profile.

By age group, adults accounted for the largest revenue share at 64.7% in 2023. Enteral feeding devices serve a wide range of adult patient populations, including individuals affected by neurological conditions such as stroke, Parkinson's disease, and traumatic brain injury, all of which can impair swallowing function. Cancer patients undergoing treatment often require enteral support to manage side effects such as nausea and gastrointestinal obstruction, while individuals with conditions like Crohn's disease may struggle to absorb adequate nutrition through oral intake alone.

By end use, hospitals are projected to expand at a striking CAGR of 45.6% through the forecast period, driven by growing clinical awareness of hospital-associated malnutrition and rising rates of ICU admission among critically ill patients requiring specialized nutritional formulations.

Regional Analysis: North America Leads, Asia-Pacific Accelerates

North America held the largest regional share in 2023, at approximately 31.58% of the global market, equivalent to USD 0.90 billion. Regional growth is being driven by the rising burden of chronic disease and surgical interventions, with cancer incidence data from national health organizations underscoring the continued need for nutritional management solutions. Strategic product introductions and regulatory clearances by key manufacturers continue to reinforce North America's position at the forefront of market innovation.

Asia-Pacific is expected to grow at a CAGR of 8.40% through the forecast period, driven by the rising prevalence of chronic disease, rapid urbanization, and aging populations across the region. As healthcare infrastructure continues to mature and access to medical care expands in countries throughout the region, there is a growing emphasis on providing comprehensive nutritional support across both clinical and home care settings.

Competitive Landscape and Recent Developments

The enteral feeding devices market remains fragmented, with prominent players pursuing partnerships, mergers, acquisitions, and product innovation to expand their footprint. Recent developments include a strategic acquisition aimed at strengthening market presence in South America's enteral feeding product segment, as well as U.S. regulatory clearance for a needleless connector device designed to reduce infection risk during fluid administration through intravascular access.

Key companies shaping the competitive landscape include Braun SE, Abbott, Boston Scientific Corporation, Conmed Corporation, Becton, Dickinson and Company (BD), Cardinal Health Inc., Avanos Medical, Inc., Neomed, Cook Medical, and Baxter, among others. These companies continue to invest in R&D, expand manufacturing capacity, and optimize supply chains to secure long-term competitive positioning.

Outlook

With enteral feeding tubes projected to retain their leading position at USD 1.74 billion in revenue by 2031, and Asia-Pacific's market value forecast to reach USD 1.21 billion, the enteral feeding devices industry appears well positioned for sustained growth. As healthcare systems worldwide continue to prioritize patient nutrition as a core component of clinical outcomes, and as home-based care models gain further traction, enteral feeding technology is likely to see continued innovation focused on safety, usability, and accessibility across both institutional and home settings.